BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23115316)

  • 21. Sunitinib-aggravated hypertension.
    Rivera F; Benounna M; Sánchez de la Nieta MD
    J Hypertens; 2009 Jul; 27(7):1502-3. PubMed ID: 19542988
    [No Abstract]   [Full Text] [Related]  

  • 22. Erosive nappy erythema following sunitinib intake.
    Kharmoum S; Errihani H
    Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
    [No Abstract]   [Full Text] [Related]  

  • 23. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
    Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
    Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute severe hypothyroidism induced by sunitinib.
    Prat A; Serrano C; Valverde C; Calvo E
    Radiother Oncol; 2008 Oct; 89(1):124-5. PubMed ID: 18502526
    [No Abstract]   [Full Text] [Related]  

  • 25. Sunitinib adverse event: oral bullous and lichenoid mucositis.
    Mignogna MD; Fortuna G; Leuci S; Pollio A; Ruoppo E
    Ann Pharmacother; 2009 Mar; 43(3):546-7. PubMed ID: 19240256
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute hepatic failure following monotherapy with sunitinib for ovarian cancer.
    Taran A; Ignatov A; Smith B; Costa SD; Bischoff J
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):971-2. PubMed ID: 18716778
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversible cardiomyopathy associated with sunitinib and sorafenib.
    Uraizee I; Cheng S; Moslehi J
    N Engl J Med; 2011 Oct; 365(17):1649-50. PubMed ID: 22030001
    [No Abstract]   [Full Text] [Related]  

  • 28. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?
    ten Freyhaus K; Homey B; Bieber T; Wilsmann-Theis D
    Br J Dermatol; 2008 Jul; 159(1):242-3. PubMed ID: 18489600
    [No Abstract]   [Full Text] [Related]  

  • 29. Imatinib-induced interstitial lung disease and sunitinib-associated intra-tumour haemorrhage.
    Loong HH; Yeo W
    Hong Kong Med J; 2008 Dec; 14(6):495-8. PubMed ID: 19060352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sunitinib-induced hand-foot syndrome: a new, distinct form.
    Fife DJ; Wu JJ; Behnam SE; Linden KG
    Clin Exp Dermatol; 2010 Mar; 35(2):200-1. PubMed ID: 19486049
    [No Abstract]   [Full Text] [Related]  

  • 31. Sunitinib-associated thrombotic microangiopathy: a significant risk.
    Buckley FD; Preston G; Meiklejohn DJ; Adamson D
    Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):515. PubMed ID: 24746506
    [No Abstract]   [Full Text] [Related]  

  • 32. Risks associated with sunitinib use and monitoring to improve patient outcomes.
    Choi BS
    Korean J Intern Med; 2014 Jan; 29(1):23-6. PubMed ID: 24574829
    [No Abstract]   [Full Text] [Related]  

  • 33. Genital and inguinal cutaneous toxicity in male and female patients treated with sunitinib.
    Iacovelli R; Mancini ML; Risi E; Palazzo A; Cortesi E
    Int J Dermatol; 2012 Feb; 51(2):221-2. PubMed ID: 22250635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma.
    Tsai KY; Yang CH; Kuo TT; Hong HS; Chang JW
    J Clin Oncol; 2006 Dec; 24(36):5786-8. PubMed ID: 17179114
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of interstitial lung disease due to sunitinib].
    Sekiguchi Z; Takizawa A; Takeshima T; Tsuchiya F; Iwasaki A; Matsuyama S; Hirooka N
    Hinyokika Kiyo; 2012 Sep; 58(9):481-5. PubMed ID: 23070386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer. Two cases.
    Schellekens AF; Mulder SF; van Eijndhoven PF; Smilde TJ; van Herpen CM
    Gen Hosp Psychiatry; 2011; 33(1):83.e1-3. PubMed ID: 21353137
    [No Abstract]   [Full Text] [Related]  

  • 37. Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
    Al Enazi MM; Kadry R; Mitwali H
    J Am Acad Dermatol; 2009 Nov; 61(5):905-6. PubMed ID: 19836653
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurosensory retinal detachment due to sunitinib treatment.
    Wegner A; Khoramnia R
    Eye (Lond); 2011 Nov; 25(11):1517-8. PubMed ID: 21852804
    [No Abstract]   [Full Text] [Related]  

  • 39. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.
    Kapiteijn E; Brand A; Kroep J; Gelderblom H
    Ann Oncol; 2007 Oct; 18(10):1745-7. PubMed ID: 17890216
    [No Abstract]   [Full Text] [Related]  

  • 40. How does sunitinib cause hypothyroidism?
    Hershman JM; Liwanpo L
    Thyroid; 2010 Mar; 20(3):243-4. PubMed ID: 20187779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.